Clinical and Genetic Studies
Currently, the Institute for Systemic Motor Research is involved in the following clinical studies:
ReMAP-FMD: A clinical trial to investigate therapeutic options for functional movement disorders
TicGenetics: Genetic study to identify the genetic factors of Tourette syndrome
Enroll-HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort – a CHDI Foundation Project
Plasma-HD a sub-study of Enroll-HD for Plasma sample collection for further genetic diagnostics
PROOF-HD Phase III study, a randomized, double-blind, placebo-controlled, multicentre, phase III study with parallel treatment arms to assess the efficacy and safety of pridopidine in patients with early stage Huntington's disease
Proof-HD OLE Open-label extension study to continue pridopidine use in patients with early-stage Huntington's disease.
Roche BN42489 Phase II study, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the safety, biomarkers and efficacy of Tominersen in patients with prodromal and early manifest Huntington´s disease
Pro PSP Prospective observational study to investigate the demographics, clinical course and biomarkers of Biomarkers of Progressive Supranuclear Gaze Palsy (ProPSP)
Pattern: Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury (PATTERN), NCT03992404
Abolish: Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort (AboLiSh), NCT04050527
StimTox: Vergleicht Botulinumtoxin und tiefe Hirnstimulation zur Behandlung der zervikalen Dystonie

- Research
- System Physiological Studies
- Clinical and Genetic Studies
- Laboratories
- Dystract